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Abstract
Background and aims
Eustachian tube dysfunction (ETD) is a commonly diagnosed disorder of Eustachian tube
opening and closure, which may be associated with severe symptoms and middle ear dis-
ease. Currently the diagnosis of obstructive and patulous forms of ETD is primarily based on
non-specific symptoms or examination findings, rather than measurement of the underlying
function of the Eustachian tube. This has proved problematic when selecting patients for
treatment, and when designing trial inclusion criteria and outcomes. This study aims to
determine the correlation and diagnostic value of various tests of ET opening and patient
reported outcome measures (PROMs), in order to generate a recommended diagnostic
pathway for ETD.
Methods
Index tests included two PROMs and 14 tests of ET opening (nine for obstructive, five for
patulous ETD). In the absence of an accepted reference standard two methods were
adopted to establish index test accuracy: expert panel diagnosis and latent class analysis.
Index test results were assessed with Pearson correlation and principle component analy-
sis, and test accuracy was determined. Logistic regression models assessed the predictive
value of grouped test results.
Results
The expert panel diagnosis and PROMs results correlated with each other, but not with ET
function measured by tests of ET opening. All index tests were found to be feasible in clinic,
and acceptable to patients. PROMs had very poor specificity, and no diagnostic value. Com-
bining the results of tests of ET function appeared beneficial. The latent class model
PLOS ONE | https://doi.org/10.1371/journal.pone.0206946 November 8, 2018 1 / 28
a1111111111
a1111111111
a1111111111
a1111111111
a1111111111
OPEN ACCESS
Citation: Smith ME, Takwoingi Y, Deeks J, Alper C,
Bance ML, Bhutta MF, et al. (2018) Eustachian tube
dysfunction: A diagnostic accuracy study and
proposed diagnostic pathway. PLoS ONE 13(11):
e0206946. https://doi.org/10.1371/journal.
pone.0206946
Editor: Kourosh Parham, University of Connecticut
Health Center, UNITED STATES
Received: August 14, 2018
Accepted: October 21, 2018
Published: November 8, 2018
Copyright: © 2018 Smith et al. This is an open
access article distributed under the terms of the
Creative Commons Attribution License, which
permits unrestricted use, distribution, and
reproduction in any medium, provided the original
author and source are credited.
Data Availability Statement: All test data are
available from the University of Cambridge data
repository: https://doi.org/10.17863/CAM.26158.
Funding: M.S. received funding from the
Cambridge Hearing Trust. The funder had no role
in study design, data collection and analysis,
decision to publish, or preparation of the
manuscript.
Competing interests: The authors have declared
that no competing interests exist.
suggested tympanometry, sonotubometry and tubomanometry have the best diagnostic
performance for obstructive ETD, and these are included in a proposed diagnostic pathway.
Conclusions
ETD should be diagnosed on the basis of clinical assessment and tests of ET opening, as
PROMs have no diagnostic value. Currently diagnostic uncertainty exists for some patients
who appear to have intermittent ETD clinically, but have negative index test results.
Introduction
The Eustachian tube (ET) is a dynamic tubular structure which normally only opens to facili-
tate gaseous pressure regulation of the middle ear, but otherwise remains closed to prevent the
transmission of sound, pressure, nasopharyngeal secretions and pathogens from the nose to
the ear. Eustachian tube dysfunction (ETD) is a frequently applied diagnosis, used when
abnormal ET function is believed to underlie any of a wide range of symptoms or middle ear
(ME) abnormalities. Two distinct forms of the disorder are recognised, representing different
ends of the spectrum of ET function: 1) obstructive ETD (OETD), in which tubal opening or
patency is reduced, and 2) patulous ETD (PETD), in which the ET is too open[1]. Even within
these two subtypes, the condition remains heterogeneous in terms of aetiology and presenta-
tion, and it has been suggested that some patients with OETD have either predominantly
active dysfunction (failure of muscle-controlled opening), or passive dysfunction (failure of
pressure-related opening)[2].
Most ETD is diagnosed on the basis of the reported clinical history, examination of the ear
and nasopharynx, and routine tests such as tympanometry. More objective tests of ET function
have been proposed, with renewed efforts in validating and developing tests in recent years
due to the need for outcome measures for emerging medical and surgical interventions. There
is no reference (gold standard) method to diagnose OETD or PETD, and the clinical diagnosis
of an experienced clinician has been the default reference standard for many years. In order to
introduce objective outcome measures to trials of ETD interventions, tympanometric classifi-
cation, Valsalva or breathing-related ME pressure change, patient reported outcome measures
(PROMs) and many other tests have been proposed as potential diagnostic markers of ETD.
Clinicians and researchers wishing to advance the diagnosis of ETD beyond clinical opin-
ion currently have difficulty determining which tests should be used. Efforts have been made
to describe the accuracy of tests that measure ET opening, and to develop PROMs[3], but diag-
nostic accuracy research is complex in conditions such as ETD where the disorder is poorly
defined and lacks a reference method for diagnosis.
Test accuracy is measured by assessing the performance of the evaluated (index) test against
the reference standard, within the same population of subjects with the suspected target disor-
der[4]. To conduct test accuracy research in conditions such as ETD, a new reference standard
can be synthesised. This may be done through: 1) a predefined rule (composite reference stan-
dard); 2) consensus among experts (panel diagnosis); 3) a statistical model based on the col-
lected test results (latent class analysis)[5, 6].
A composite reference standard for ETD is not possible due to the lack of evidence relating
existing tests to the condition.
An expert panel can be used as a reference standard by establishing the presence or absence
of a disorder in individual patients. The expert panel method is suited to conditions such as
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ETD where multiple sources of information such as patient characteristics, symptoms, exami-
nation findings and other test results must be interpreted in a judicious way to reach a diagno-
sis, particularly in the absence of an unequivocal definition of the disorder[5].
Latent class analysis uses a statistical model to combine different test results from each
patient to construct a reference standard. The technique aims to determine the latent variable
(diagnosis) on the basis of manifest variables (the test results). Latent class models perform
well if there are large numbers of index tests, as they increase the possible test combinations
and available degrees of freedom. However, these models require test results to be indepen-
dent, and so not all possible ETD tests can be modelled together.
Both diagnosis and test accuracy are heavily influenced by the situation and cohort in
which they are assessed. Most tests for ETD have not been investigated in a representative clin-
ical setting where patients have an uncertain diagnosis. In contrast, most tests have been
assessed in a case-control design study, with cases selected to represent a single, often more
severe form of ETD are matched with healthy controls. These two factors tend to overestimate
test accuracy, as in practice the task is to differentiate subjects who are disease positive from
subjects who have many of the same symptoms, but do not have the disorder[7, 8]. In addition,
most tests have been assessed for diagnostic accuracy in isolation, missing the potential
improvement that may be gained by combining test results, either informally as part of the
diagnostic process, or mathematically in a risk calculator.
Finally, the status of clinical assessment as the current default reference standard diagnosis
for ETD has not been challenged. Instead, tests that do not support the clinical reference diag-
nosis have been deemed inaccurate. The converse is of course possible. Without the assessment
of multiple and varied tests in a single cohort, it has not been possible to establish the correla-
tion between different diagnostic methods, and the accuracy of clinical diagnosis.
This prospective diagnostic accuracy study aims to explore the relationship between results
from a wide range of different methods for diagnosing ETD, and to establish their accuracy
compared to a reference standard, generated using both latent class analysis and panel diagno-
sis. We discuss the clinical implementation of these tests, and a recommended diagnostic
pathway.
Methods and materials
Ethical approval was obtained from the UK Research Ethics Service. Written consent was
obtained from all participants.
Participants
A single cohort of non-consecutive patients with symptoms or examination findings sugges-
tive of ETD were selectively recruited from ENT outpatient clinics at Addenbrooke’s Hospital,
Cambridge, between November 2016 and May 2017, according to the following criteria:
Inclusion criteria.
�18 years old
One of the following findings (formalising current clinical practice):
• at least 2 symptoms of ETD�
• AND/OR tympanic membrane retraction
• AND/OR negative pressure tympanogram (�-100daPa)
�list in S1 Table, and based upon a literature review.
Exclusion criteria.
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• Otoscopic findings that may prevent use of the full range of index tests (otitis media with
effusion, tympanic membrane perforation$, cholesteatoma, discharging or infected ear)
• Cardiac pacemaker (incompatible with the sonotubometry speaker)
• Patients with cleft palate or craniofacial abnormality (due to concerns regarding their ability
to perform the full range of tests, or to obtain interpretable results)
• Inability to consent or poor understanding of written English
Assessments
Recruited patients initially underwent an assessment equivalent to the current standard of care
in clinics without a specialist interest in ETD. Patients then underwent assessment with vari-
ous tests for ETD (index tests).
Standard-of-care assessment (4 components).
1. A focused, standardised clinical history of the patient’s presenting complaint, screening for
symptoms and medical history associated with ETD.
2. Otoscopic examination: recording retraction, atelectasis, and other relevant features of the
tympanic membrane.
3. Pure tone audiometry with air and bone conduction thresholds.
4. Middle ear pressure and compliance measured via tympanometry.
Index tests. Two forms of ET function test were assessed as index tests: objective and
semi-objective measures of ET opening, and symptom-based PROMS. Tests of ET opening for
OETD (9 tests) and PETD (5 tests) were performed according to optimal methods previously
identified[9, 10] or standard procedure (PETD tests). Details of the tests of ET opening, their
various methods and the repeats performed can be found in Table 1. Two PROMs were com-
pleted by patients: the CETDA[11] and ETDQ-7[12]. Composite measures of ET function
were also assessed: the 5- and 7-item Eustachian Tube Scores (ETS and ETS-7) were calculated
for each case, combining patient-reported symptoms with tubomanometry results in a simple
numerical scale, with lower scores indicative of OETD[13].
All participants underwent all OETD and PETD tests in a single session, with a single asses-
sor (MS). Although previous work suggested fatigue and test interactions were minimal[10],
the index tests were applied in a partly-randomised manner; tympanometry and the nine step
test were always applied first to prevent residual middle ear pressure influencing results, while
the order of the other tests was randomised using an online random sequence generator[14].
PROMs were also completed in a randomised order.
To assess feasibility in clinical practice, and the burden on the patient, for each test we also
recorded: time taken to complete the test from start of patient instruction to end of data
recording (min/sec); patient reported difficulty in completing the test (Likert scale 1–10,
1 = none, 10 = almost impossible); and discomfort during the test (Likert scale 1–10, 1 = none,
10 = almost unbearable).
Data were recorded on paper forms and in Microsoft Excel.
Expert panel diagnosis
A six-person international expert panel was recruited from clinicians working and publishing
in the field of ETD. The panel’s role was to provide a reference standard diagnosis of ETD,
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Table 1. Tests of ET opening assessed, including manoeuvres used and number of repeats.
ET Function Test Method (no. of
measurements)
Diagnostic outcome measured
(unit)
Other variables recorded (unit)� ET function tested
Obstructive ETD
Tympanometry Patient at rest (1) ME pressure (daPa)
Tympanic admittance (ml)
- Active opening
(ME pressure also influenced
by mucosal gas exchange)
Nine-step test 3 dry swallows, +400daPa
in EAC (1)
3 dry swallows, - 400daPa
in EAC (1)
ME pressure change after ±400daPa
(daPa)
ME pressure change after
equilibration (daPa)
- Active opening
Patient-reported assessment Valsalva (3)
Dry Toynbee (3)
Patient sensation (yes/no) - Passive opening (Valsalva)
Passive and active opening
(Toynbee)
Observation of the tympanic
membrane
Valsalva (3)
Dry Toynbee (3)
Tympanic membrane movement
(yes/no)
Strength and speed of TM
movement (weak/strong, fast/
slow)
Passive opening (Valsalva)
Passive and active opening
(Toynbee)
Tubo-tympano-aerodynamic-
graphy (TTAG)
Valsalva (3)
Dry Toynbee (3)
Peak positive and negative change in
EAC pressure (daPa)
NP pressure (daPa) Passive opening (Valsalva)
Passive and active opening
(Toynbee)
Continuous impedance Valsalva (3)
Dry Toynbee (3)
Peak positive and negative change in
tympanic impedance (ml)
NP pressure (daPa) Passive opening (Valsalva)
Passive and active opening
(Toynbee)
Sonotubometry Dry swallow (5) Peak EAC sound pressure level (dB)
Duration of EAC recording (ms)
- Active opening
Tubomanometry Wet swallow, 300daPa
(1)
Wet swallow, 400daPa
(1)
Wet swallow, 500daPa
(1)
Peak EAC pressure change (daPa)
R value (No unit)
- Passive and active opening
Tuboimpedance Wet swallow, 300daPa
(1)
Wet swallow, 400daPa
(1)
Wet swallow, 500daPa
(1)
Peak tympanic impedance change
(ml)
- Passive and active opening
Patulous ETD
Observation of the tympanic
membrane
10 seconds heavy
breathing (1)
Breathing synchronous tympanic
membrane movement (yes/no)
- Passive closure
TTAG 10 seconds heavy
breathing (1)
Breathing synchronous change in
EAC pressure (daPa)
- Passive closure
Continuous impedance 10 seconds heavy
breathing (1)
Breathing synchronous change in
tympanic impedance (ml)
- Passive closure
Sonotubometry 10 seconds heavy
breathing (1)
Breathing synchronous change in
EAC sound pressure level (dB)
- Passive closure
Tubomanometry Wet swallow, 300daPa
(1)
Wet swallow, 400daPa
(1)
Wet swallow, 500daPa
(1)
R value (No unit) - Passive and active opening
ME = middle ear, NP = nasopharyngeal, EAC = external auditory canal, TTAG = Tubo-tympano-aerodynamic-graphy. In addition for each test the following were
recorded; time taken to complete the test (min/sec), patient reported difficulty to complete the test (Likert scale 1–10, 1 = none) and discomfort during the test (Likert
scale1-10, 1 = none).
https://doi.org/10.1371/journal.pone.0206946.t001
Diagnosis of Eustachian tube dysfunction
PLOS ONE | https://doi.org/10.1371/journal.pone.0206946 November 8, 2018 5 / 28
through the consensus opinion of experts. The six experts were divided into two groups, form-
ing Panel A (MBa, MBh, ND) and Panel B (CA, DP, JT).
To reduce assessor burden, study participants were randomly allocated into two groups for
independent review by one of the two panels. To ensure that each panel had a similar case mix,
allocation was stratified according to original clinic diagnosis (OETD / PETD / alternate diag-
nosis). As part of the allocation process, a subgroup of 20 patients was allocated to both panels
to assess inter-panel agreement. The random sampling was done by YT using PROC SUR-
VEYSELECT in the SAS statistical package.
Each patient’s history, examination and audiometry findings were presented to the panel
on a separate case summary slide (Microsoft Powerpoint). Summary slides included informa-
tion available in ENT outpatients (including the results of investigations (e.g. nasendoscopy or
imaging), and the response to treatments initiated in the community (e.g. nasal steroid spray,
or betahistine). Index test results were not presented to the panel to prevent incorporation bias
falsely inflating test accuracy[8], with the exception of tympanometry, as this test is established
and widely available in current ENT practice.
Initially, each panel member assessed cases independently and without conferring. They
were asked to diagnose ETD if they felt it was present, even if some symptoms, or the primary
complaint, were thought to be due to another condition. Panel members were asked to con-
sider three possible diagnoses: OETD, PETD, or an alternate diagnosis.
Results from individual expert assessment were analysed, and where all three experts in a
panel agreed on a diagnosis, this diagnosis was assigned. Disagreements were subsequently
discussed at a panel teleconference (Fig 1) where panels A&B met separately. Summary data
for each study participant were reviewed and panel members discussed the reasons for their
individual diagnoses. The panels were directed to reach a consensus diagnosis if possible.
Where consensus could not be reached, the diagnosis was made by a majority vote of 2–1.
Rules were set in advance to assign a diagnosis in the event that there was disagreement
between the panels A&B when diagnosing the subset of 20 shared cases:
1. Diagnoses made via individual diagnoses in agreement were assigned over those with initial
disagreement
2. Diagnoses made at discussion via consensus were assigned over those made by a 2:1 vote
3. If rule 1 or 2 could not be applied, (i.e. there were conflicting diagnoses from panels A&B,
made in an equivalent manner) the diagnosis was recorded as indeterminate.
Agreement between panels for the 20 shared cases was measured with Cohen’s Kappa.
Statistical analysis and modelling
Raw test data were initially analysed using descriptive statistics in accordance with diagnostic
criteria described in the literature and previous work[9, 10].
Assessment of correlation and latent variables. Principle component analysis (PCA) was
used to detect common latent variables within the test outcomes. PCA was performed using con-
tinuous or ordinal variables from each of the tests and PROMs, and the panel diagnosis. To con-
firm adequacy of sampling, the Kaiser-Meyer-Olkin (KMO) value was calculated (>0.6
adequate), and Bartlett’s Test of Sphericity performed. Components with an Eigenvalue<1 were
disregarded. Pairwise correlations for the function tests, PROMs and panel diagnosis were per-
formed by creating a correlation matrix (bivariate Pearson correlation). PCA and correlation
were performed with SPSS 25 (IBM, Armonk, New York, USA). An explanatory description of
PCA and latent class analysis (see below) is included in the Supporting Information (S1 File).
Diagnosis of Eustachian tube dysfunction
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Test accuracy based on expert panel as reference standard. Estimation of the accuracy
of individual tests: Using the panel diagnosis, 2x2 tables were generated for each index test.
For tests measured on a continuous or ordinal scale, sensitivity and specificity were calculated
at pre-specified and novel diagnostic thresholds (Table 2, column 3). As test repetitions were
employed to improve repeatability of findings[10], novel thresholds using the repetitions were
generated to allow interpretation. Receiver operating characteristic (ROC) curves were also
plotted and the area under the curve (AUC) estimated. Thresholds at which sensitivity was
maximised and the false positive rate was minimised were identified on ROC curves. Test per-
formance was also summarised using Youden’s index (J, where J = sensitivity + specificity– 1)
where 1 indicates a perfect test and 0 indicates no diagnostic value[15]. Accuracy was assessed
for tests of both patulous and obstructive ETD.
Development of a diagnostic model using multiple tests: The potential value of combining
multiple tests was explored. Using penalised maximum likelihood estimation logistic regres-
sion, multivariable models were developed for predicting the likelihood of OETD. The LASSO
(least absolute shrinkage and selection operator) penalty term was used[16]. The strategy was
to fit models to a fixed set of predefined tests, and the LASSO approach may shrink some
Fig 1. Flow chart demonstrating the data collection process and generation of a reference standard, with subsequent analysis to assess test accuracy.
https://doi.org/10.1371/journal.pone.0206946.g001
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Table 2. Summary of test results for ETD, with different interpretation methods.
Test Parameter Interpretation for OETD Median % cases Expert Panel Diagnosis
positive AUC
(95% CI)
Sensitivity
(95% CI)
Specificity
(95% CI)
Youden’s
index J
Obstructive ETD n = 57 OETD n = 57 non-
OETD
Tympanometry Patient at rest Raw data–ME pressure in daPa -11 - 0.66 (.56-
.76)
- - -
<-50 daPa - 23.1 - 35.1 (22.9–
48.8)
91.2 (80.7–
97.0)
0.26
<-100 daPa - 15.4 - 26.3 (15.5–
39.6)
98.2 (90.6–
100.0)
0.25
Nine-step test +400daPa Raw data—daPa change -15 - 0.60 (.50-
.71)
- - -
<5DaPa change - 25.0 - 31.6 (19.9–
45.2)
80.7 (68.0–
89.9)
0.12
<10DaPa change - 35.6 - 45.6 (32.3–
59.3)
73.7 (60.3–
84.4)
0.19
+ve
equilibration
Raw data—daPa change 6 - 0.62 (.52-
.72)
- - -
<5DaPa change - 35.6 - 38.6 (25.9
52.4)
66.7 (52.9–
78.5)
0.05
<10DaPa change - 51.0 - 63.2 (49.3–
75.5)
61.4 (47.5–
74.0)
0.25
- 400daPa Raw data—daPa change 9 - 0.46 (.36-
.55)
- - -
<5DaPa change - 47.1 - 59.6 (38.9–
66.0)
57.9 (44.0–
70.8)
0.11
<10DaPa change - 56.7 - 64.9 (51.1–
77.0)
49.1 (35.6–
62.7)
0.14
-ve
equilibration
Raw data—daPa change -3 - 0.58 (.48–
68)
- - -
<5DaPa change - 53.8 - 63.2 (49.3–
75.5)
50.9 (37.2–
64.3)
0.14
<10DaPa change - 66.3 - 75.4 (62.2–
85.8)
38.6 (25.9–
52.4)
0.14
±400daPa Number results <5DaPa change /4 - - 0.60 (.49-
.69)
- - -
together Number results <10DaPa change /4 - - 0.64 (.54-
.74)
- - -
Any of 4 results <5DaPa change - 77.9 - 80.7 (68.0–
89.9)
38.6 (25.9–
52.4)
0.19
Any of 4 results <10DaPa change - 70.2 - 87.7 (76.3–
94.9)
29.8 (18.4–
43.4)
0.18
Patient-reported Valsalva Count no open out of 3 - - 0.61 (.51-
.71)
- - -
�2 out of 3 +ve - 45.2 - 56.1 (42.3–
69.2)
61.4 (47.5–
74.0)
0.18
Dry Toynbee Count no open out of 3 - - 0.61 (.51-
.71)
- - -
�2 out of 3 +ve - 66.3 - 77.2 (64.1–
87.2)
45.6 (32.3–
59.3)
0.23
Observed TM Valsalva Count no open out of 3 - - 0.68 (.58-
.78)
- - -
�2 out of 3 +ve - 47.1 - 61.4 (42.3–
69.2)
61.4 (47.5–
74.0)
0.18
(Continued)
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Table 2. (Continued)
Test Parameter Interpretation for OETD Median % cases Expert Panel Diagnosis
positive AUC
(95% CI)
Sensitivity
(95% CI)
Specificity
(95% CI)
Youden’s
index J
Dry Toynbee Count no open out of 3 - - 0.67 (.58-
.77)
- - -
�2 out of 3 +ve - 61.5 - 73.7 (60.3–
84.4)
54.4 (40.6–
67.6)
0.28
TTAG Valsalva Count no open out of 3 - - 0.59 (.49-
.70)
- - -
�2 out of 3 +ve - 41.3 - 49.1 (35.6–
62.7)
70.2 (56.5–
81.5)
0.19
Dry Toynbee Count no open out of 3 - - 0.61 (.51-
.71)
- - -
�2 out of 3 +ve - 52.9 - 59.6 (45.8–
72.4)
59.6 (45.8–
72.4)
0.19
Continuous
impedance
Valsalva Count no open out of 3 - - 0.61 (.51-
.71)
- - -
�2 out of 3 +ve - 37.5 - 43.9 (30.7–
576)
71.9 (58.4–
83.0)
0.16
Dry Toynbee Count no open out of 3 - - 0.68 (.58-
.77)
- - -
�2 out of 3 +ve - 52.9 - 66.7 (52.9–
785)
66.7 (52.9–
78.5)
0.33
Sonotubometry Dry swallow Raw data–mean dB 5 - 0.41 (.31-
.51)
- -
<0dB count out of 5 - - 0.57 (.47-
.68)
- - -
<5dB count out of 5 - - 0.58 (.47-
.68)
- - -
<10dB count out of 5 - - 0.59 (.49-
.70)
- - -
3 out of 5 <0dB - 37.5 - 45.6 (32.3–
59.3)
70.2 (56.5–
81.5)
0.16
3 out of 5 <5dB - 47.1 - 56.1 (42.3–
69.2)
59.6 (45.8–
72.4)
0.16
3 out of 5 <10dB - 58.7 - 66.7 (52.9–
78.5)
47.4 (33.9–
61.0)
0.14
Tubomanometry 300daPa No open or R >1 - 56.7 - 68.4 (54.7–
80.0)
59.6 (45.8–
72.4)
0.28
400daPa No open or R >1 41.3 49.1 (35.6–
62.7)
70.2 (56.5–
81.5)
0.19
500daPa No open or R >1 39.4 47.4 (33.9–
61.0)
71.9 (58.4–
83.0)
0.19
All 3 pressures No open or R >1 out of 3 - - 0.65 (.55-
.75)
- - -
Tuboimpedance 300daPa No open - 26.9 - 36.8 (24.4–
50.6)
84.2 (72.1–
92.5)
0.21
400daPa No open - 19.2 26.3 (15.5–
39.6)
86.0 (74.2–
93.7)
0.12
500daPa No open - 7.7 12.3 (5.0–
23.6)
96.5 (87.8–
99.5)
0.09
All 3 pressures No opens out of 3 - - 0.60 (.50-
.70)
- - -
(Continued)
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coefficients to zero. Thus, the approach provided a form of variable selection in addition to
correcting for optimism and preventing very extreme predictions[17]. Two models were
designed containing tests grouped by current clinical application. In one model (Research
model), both routine tests and function tests that are infrequently used were included. In a sec-
ond, simpler model (Clinical model), only tests that are routinely available in clinical practice
were included. Diagnostic thresholds were not applied to continuous variables.
Tympanic pressure was considered by the clinical panel in making the final diagnosis of
OETD, leading to potential for incorporation bias. Therefore, in sensitivity analyses this vari-
able was excluded from some models, to explore whether the diagnostic value of the models
was mainly driven by middle ear pressure.
Assessment of diagnostic model performance and internal validation: Model performance
was assessed in terms of discrimination and calibration. Discrimination is the ability of the
Table 2. (Continued)
Test Parameter Interpretation for OETD Median % cases Expert Panel Diagnosis
positive AUC
(95% CI)
Sensitivity
(95% CI)
Specificity
(95% CI)
Youden’s
index J
CETDA Total score Score 27 - 0.60 (.49-
.69)
- - -
Score�17 - 81.8 - 87.7 (76.3–
94.9)
24.6 (14.1–
37.7)
0.12
ETDQ-7 Total score Score 25 - 0.59 (.48-
.69)
- - -
Score�15 - 71.0 - 80.7 (68.0–
89.9)
24.6 (14.1–
37.7)
0.05
ETS Total score Score 4 - 0.60 (.50-
.70)
- - -
Score�5 - 62.5 - 71.9 (58.4–
83.0)
43.9 (30.7–
57.6)
0.16
ETS7 Total score Score 6 0.67 (.57-
.77)
- - -
Score�7 - 59.6 - 68.4 (54.7–
80.0)
47.4 (33.9–
61.0)
0.16
Patulous ETD n = 12 PETD n = 102 non-
PETD
Observed TM Heavy
breathing
+ve for change with breathing - 4.8 - 33.3 (9.9–
65.1)
99.0 (94.6–
100.0)
0.32
TTAG Heavy
breathing
+ve for change with breathing - 7.7 - 50.0 (21.0–
78.9)
98.1 (93.0–
99.8)
0.48
Impedance Heavy
breathing
+ve for change with breathing - 6.7 - 50.0 (21.0–
78.9)
99.0 (94.6–
100.0)
0.49
Sonotubometry Heavy
breathing
+ve for change with breathing or ET remains
open after swallowing
- 1.9 - 8.3 (0.2–38.4) 99.0 (94.6–
100.0)
0.07
Tubomanometry 300daPa R value < 0.2 - 5.8 - 33.3 (9.9–
65.1)
98.1 (93.0–
99.8)
0.31
400daPa R value < 0.2 - 4.8 - 33.3 (9.9–
65.1)
99.0 (94.6–
100.0)
0.32
500daPa R value < 0.2 - 5.8 - 25.0 (5.4–
57.1)
97.1 (91.6–
99.4)
0.22
Expert panel as the reference standard. CETDA = Cambridge Eustachian Tube Dysfunction Assessment, ETDQ-7 = Eustachian Tube Dysfunction Questionnaire 7,ETS
(7) = Eustachian Tube Score (7), TTAG = tubo-tympanic aerodynamic graphy, TM = tympanic membrane
https://doi.org/10.1371/journal.pone.0206946.t002
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model to distinguish a patient with the endpoint OETD from a patient without OETD (with
PETD or alternative diagnosis). The c-statistic for evaluating the discriminatory ability of a
logistic regression model is equivalent to the ROC AUC. A c-statistic of 1.0 indicates perfect
discrimination while a c-statistic of 0.5 indicates random discrimination[18]. For internal vali-
dation of the model discrimination, bootstrapping with 200 samples was used to obtain opti-
mism-adjusted estimates of model performance statistics[18–20]. Calibration, the agreement
between observed endpoints and predictions[21] was also assessed, with methodology for this
and internal validation in the Supporting Information (S1 File).
Test accuracy based on latent class analysis. Latent class analysis (LCA) was used to
combine multiple test results in order to estimate the proportion of patients with OETD, and
the sensitivity and specificity of each of the index tests included in a 2-class latent class model.
For LCA to be valid, the tests included in the analysis should be independent, measuring ETD
in a distinct manner. Therefore, one test was selected for each aspect of ETD function (Table 1,
column 5,), except where the test was considered sufficiently distinct (e.g. sonotubometry and
impedance Toynbee for active opening).
When diagnosing ETD, there is no clear incentive to prioritise either sensitivity or specific-
ity over the other. Therefore, for each test, the diagnostic threshold with the highest Youden’s
index was selected for dichotomising ordinal and continuous test results, and LCA models
were fitted. Four models were fitted: All-test model, with the panel diagnosis included as an
index test alongside the tests of ET opening and PROMs; No-panel model, the all-test model
without the panel diagnosis; No-PROMmodel, the All-test model without the PROM, and the
Open-test model only including tests that measure ET opening. Each model containing a
PROM included either the CETDA or ETDQ-7 (model variant A and B respectively). In addi-
tional variations of the models, tympanic pressure was excluded, since results from this test
were used by the panel in making the final diagnosis for each patient.
LCA and regression analyses were performed using Stata 15 (StataCorp LP, College Station,
Texas, USA).
Assessment of fatigue during repeated testing. Patients were required to repeatedly per-
form manoeuvres during assessment with TTAG, impedance and sonotubometry tests. To
assess for evidence of fatigue and reducing ability, the nasopharyngeal pressures and results
across the required 3–5 repetitions were compared using two-tailed AVOVA.
Results
Data were obtained from 116 patients. Patient characteristics are outlined in Table 3. Six of the
116 patients were incorporated in analysis but had one missing test result due to: sonotubome-
try contraindicated with pacemaker (n = 1); erratic impedance baseline (n = 2); and erratic
sonotubometry baseline (n = 3). An additional five patients were recruited but were later
excluded (one withdrew consent during testing, three were unable to perform tubomanome-
try/tuboimpedance, and one could not complete the PROMs). One patient aspirated water
during tubomanometry but quickly recovered, no other adverse events were recorded.
Expert panel diagnosis
Panel diagnoses were assigned as shown in Fig 2. Of the 116 patients, 57 (49.1%) had OETD,
12 (10.3%) had PETD and 45 (38.8%) had alternate diagnoses. For the remaining two (1.7%)
patients, the panels could not agree and so the diagnosis for these patients was classified as
indeterminate and they were excluded from further analysis. The proportion of cases assigned
each primary diagnosis was similar between panels. In the 20 cases reviewed by both panels
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the diagnoses agreed in 15 individuals (75%), with Cohen’s κ = 0.55 (95% CI 0.21–0.89), repre-
senting a moderate strength of agreement[22].
Patterns and correlations
Principle component analysis suggested the presence of four significant latent components
(Eigenvalue>1) underlying the results of the OETD tests of ET opening, PROMs and panel
diagnosis. All tests of ET opening weighted positively on the first component (which
accounted for the greatest variance across all test results), while symptoms had a weak negative
weighting on this component (Table 4). This pattern suggested that the first component repre-
sented ET function in terms of tube opening, as expected with the dataset mainly formed from
tests of ET opening. The tests loading strongly for component 2 were the two PROMs and the
panel diagnosis, while the tests of ET opening loaded weakly or negatively for this component;
this component therefore appeared to relate to symptoms. The similar loading for the PROMs
and panel diagnosis is not surprising, as symptoms are likely to have been a strong driving fac-
tor in the panel diagnosis. However, the loading patterns for components 1 and 2 suggest that
symptoms and ET opening are distinct aspects of ETD which vary independently.
For component 3, all tests measuring only passive ET opening had positive loading, while
those measuring active and mixed opening all had negative loading. This suggests that passive
and active ET dysfunction may be distinct, with some individuals expressing primarily passive
or active dysfunction on tests of ET opening. Passive ET opening appeared more related to
ETD symptoms than active opening on the basis of the loading for component 3. Loading for
component 4 was overall weak with no clear pattern relating it to an attribute of ETD. PCA
was not suitable to analyse PETD test results given the small PETD sample size.
In the OETD correlation matrix incorporating OETD tests of ET opening, PROMs and the
panel diagnosis (S2 Table), most tests of ET opening correlated with one another, with only 4
of 78 pairings demonstrating p�0.05. All opening test pairs with differences in results that
showed a p�0.01 comprised tests that measured different aspects of ET function (e.g. active
and passive opening), further suggesting that some patients may have predominantly active or
Table 3. Demographic and clinical characteristics of 116 participants.
Characteristic No. (%) Mean ±SD
Age, years 50 ±16.3
Male 50 (43)
Test ear Contralateral ear Test ear Contralateral ear
Right ear 59 (48) -
Otoscopy normal 96 (83) 86 (76)
Tympanogram type
Type A 101 (87) 95 (82)
Type B 0� 15 (13)
Type C 15 (13) 6 (5)
Middle ear pressure, daPa -36.0 ±73.0 -46.9 ±50.2
PTA�, dB 26.8 ±19.6 —
PTA�� >20dB 61 (54) —
Any symptoms present 113 (97) 69 (59)
PTA = pure tone audiogram, SD = standard deviation
�type B tympanogram ears were excluded as not compatible with some tests
��average pure-tone hearing threshold levels at 500, 1000, 2000 and 4000Hz
https://doi.org/10.1371/journal.pone.0206946.t003
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passive ET dysfunction. The pairwise correlation between PROM scores and tests of ET open-
ing was insignificant (p�0.05) in almost all cases, demonstrating a limited relationship
between a patient’s symptoms and ET opening, as seen in the PCA. Also as suggested by the
PCA, in the matrix the panel diagnosis was found to be correlated with PROM scores and not
significantly correlated with most tests of ET opening. The lack of correlation between the
panel diagnosis and tympanometry suggested that panel knowledge of tympanometry results
had not led to significant incorporation bias: an important finding when including the test in
the statistical models.
In contrast to OETD, the PETD correlation matrix (S3 Table) showed a different pattern,
with the PETD panel diagnosis significantly correlated with the PETD tests of ET opening,
and less strongly correlated with the PROMs. Again, the PROMs and tests of ET opening did
not correlate.
Fig 2. Flow chart for the expert panel diagnostic process. Rules were set to assign a diagnosis in the event of disagreement between panels A&B: 1. Diagnoses
made via individual agreement were assigned over those with initial disagreement; 2. Diagnoses made at discussion via consensus were assigned over those
made by a 2:1 vote; 3. If rule 1 or 2 could not be applied, the diagnosis was recorded as indeterminate.
https://doi.org/10.1371/journal.pone.0206946.g002
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Test accuracy with panel diagnosis as reference standard
Table 2 presents estimates of test accuracy from all obstructive and patulous ETD tests using
expert panel diagnosis as the reference standard. Diagnostic performance measured by the
AUC and Youden’s index was in many cases poor: no single test had sensitivity and specificity
>65% or J>0.5. Some tests had high sensitivity or specificity, depending on the threshold
applied. Tests for PETD performed better than those for OETD, with higher specificity. ETS
and ETS-7 scores were not assessed beyond this stage as they are composite scores incorporat-
ing the results of other index tests.
The low number of PETD cases (12 panel-diagnosed cases) prevented further analysis of
the diagnostic accuracy of tests for PETD using LCA or regression modelling.
Selection of tests for inclusion in LCA and logistic regression models. For the regres-
sion analyses, all nine OETD tests of ET opening were included with the CETDA or ETDQ-7
in the Research model (Table 5), following selection of the test variant and threshold with the
Table 4. Principle component analysis matrix.
Aspect of OETD Test and parameter Component
1 2 3 4
Passive opening Observed Valsalva
Count/3
0.79 -0.09 0.34 0.20
Reported Valsalva
Count/3
0.65 -0.07 0.32 0.37
TTAG Valsalva
Count/3
0.61 -0.31 0.60 0.01
Impedance Valsalva
Count/3
0.64 -0.15 0.50 -0.23
Active opening Observed Toynbee
Count/3
0.73 0.10 -0.15 0.32
Reported Toynbee
Count/3
0.61 0.13 -0.32 0.53
TTAG Toynbee
Count/3
0.66 -0.09 -0.23 0.01
Impedance Toynbee
Count/3
0.77 0.12 -0.24 -0.24
Sonotubometry
<5dB count/5
0.62 0.11 -0.32 -0.01
Both forms of opening Tubomanometry 300 & 400daPa�
R>1 or no open count/2
0.60 0.22 -0.11 -0.50
Tuboimpedance
no-open count/3
0.61 0.17 -0.04 -0.52
Pressure equalisation Nine step
ME change <10daPa count/4
0.50 0.23 -0.43 0.00
Tympanometry
ME pressure daPa
0.44 -0.33 -0.04 0.27
Symptoms CETDA
Total score
-0.07 0.89 0.32 0.13
ETDQ-7
Total score
-0.15 0.91 0.26 0.02
All Expert panel diagnosis
OETD, PETD or alternate diagnosis
0.17 0.53 0.02 0.21
Positive loading >0.3 is highlighted with grey shading. n = 114.
�500daPa excluded as test performed poorly
https://doi.org/10.1371/journal.pone.0206946.t004
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highest Youden’s index (based on results in Table 2). For LCA the same process was adopted
to identify suitable variables, although some tests were excluded to ensure that those incorpo-
rated in the model were distinct, and not prone to similar test errors. To do this, a judgement
was made on the basis of the underlying principle and methodology of each test. Selected tests
were then grouped according to the four previously defined models (Table 5). For sonotubo-
metry, a threshold of 5 or 10dB was not clearly superior, and so accuracy at each of the two
thresholds was initially assessed in regression and LCA models. For tympanometry, thresholds
of -50 and -100daPa were explored, with -50daPa found to give a higher accuracy, and corre-
late more closely with other tests of ET opening.
Multivariable diagnostic models. While using the expert panel as the reference standard,
the benefit of combining test results was explored. The outputs from the Clinical and Research
models are shown in Table 6. Patient-reported Valsalva, TTAG Valsalva, sonotubometry (both
5 and 10dB thresholds) and tuboimpedance were de-selected in one or both of the models due
to shrinkage of their coefficients to zero.
1) Discriminatory ability of multivariable diagnostic models. The c-statistic was superior
for both the Clinical and Research models (Table 7, ROC curves in S1 Fig) when compared to
equivalent AUC values for the individual index tests (Table 2). The choice of PROM included
(CETDA or ETDQ-7) had little effect on the performance of the models. The addition of more
complex tests mainly used in research did not markedly improve accuracy above that seen
when only tests used in standard clinical practice were included (optimism corrected c-statistic
was 0.74 for clinical models and 0.76–0.77 for research models).
2) Calibration of multivariable diagnostic models. The calibration slope was between 0.79
and 0.83 for all regression models, as expected with relatively small datasets. This finding sug-
gests that predictions made by the models regarding the probability of OETD are likely to be
too extreme: low predictions too low, and high predictions too high[17] (calibration plots in
S2 Fig).
Latent class models
LCA provided an opportunity to assess the expert panel diagnosis as an index test along with
other index tests. Results from the four LCA models are shown in Table 8i-iii. The proportion of
cases assigned to the OETD class was 31.6–32.5% in models without the panel diagnosis, and
38.5–40.2% in models with the panel diagnosis. Because the latent variable (the OETD diagnosis)
is unobserved it was not possible to determine if it was the same cases classified as OETD in the
models with similar results, but this is the assumption given the stability of the findings[23].
The addition of the panel diagnosis to the simpler models had a consistent effect: reducing the
sensitivity and specificity of all other index tests by classifying a greater proportion of the cohort
as OETD cases. In contrast, the addition of either the CETDA or ETDQ-7 to the models had little
impact on class allocation, with the models suggesting the PROMs had no diagnostic value, J =
-0.09 to 0.10. All models, with and without the panel diagnosis, demonstrated a consistent finding
that tympanometry, sonotubometry and tubomanometry (using 300daPa) provided the greatest
diagnostic value, being the only tests with J>0.5. Tests measuring ME pressure equalisation
tended to have had higher specificity than tests measuring other aspects of ET opening.
Tympanometry was excluded from early models (not shown) due to concern over incorpo-
ration bias, but the effect on the model of including tympanometry seemed similar to the effect
of other tests of ET opening, and unlike the effect of including the panel diagnosis. Sonotubo-
metry interpreted with a 10dB threshold was included in some early LCA models, but was
excluded due to model instability, unlike when sonotubometry was included at a 5dB
threshold.
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Fatigue. There was no evidence of a systematic change in patient manoeuvre ability (mea-
sured by generated nasopharyngeal pressure) or test results across the immediate test repeats
(ANOVA p value range 0.40–0.98) (S4 Table).
Patient and assessor burden. All tests could be completed in a sufficiently short period of
time by a single trained individual for them to be practical for use in routine clinics. The mean
time taken to perform all objective tests together was 40 min 21 sec (SD 283 sec), in addition to
the time for PROM completion (not timed). The recorded time to complete each test included
patient instruction, attempts to gain competence or useable data (if required), and data record-
ing (Table 9). Tests were well tolerated overall, with difficulty and discomfort ratings highest
for tubomanometry and tuboimpedance (Table 9), reported by patients to be due to the
applied sudden-onset nasopharyngeal pressure during these tests.
Discussion
Eustachian tube dysfunction is poorly defined and often presents a diagnostic challenge to cli-
nicians. OETD or PETD diagnoses have often been applied to patients (or individual ears)
based on clinical assessment relying on symptoms, otoscopy, tympanometry and pure tone
Table 5.
Combined test models Latent class models
Aspect of ETD
evaluated
Selected ET function
test
Regression
variable
Clinical
model
Research
model
Threshold for test
positivity
All-test
Model
No-
panelModel
No-PROM
Model
Open-test
Model
Symptoms� CETDA score Total score ✓ (a) ✓ (a) Score�17 ✓ (a) ✓ (a)
ETDQ7 score Total score ✓ (b) ✓ (b) Score�15 ✓ (b) ✓ (b)
ME pressure
equalisation
Nine step test
Tympanometry
+400 change in
daPa
ME pressure in
daPa
✓
✓
✓
+400 change
<10daPa
<-50daPa
✓
✓
✓
✓
✓
✓
✓
✓
Passive opening Observed Valsalva
Patient-reported
Valsalva
TTAG Valsalva
No. opening out of
3
No. opening out of
3
No. opening out of
3
✓
✘
✓
✘
✘
2 out of 3 no open
2 out of 3 no open
2 out of 3 no open
✓ ✓ ✓ ✓
Active opening Sonotubometry
Impedance Toynbee
Observed Toynbee
Patient-reported
Toynbee
No. opening out of
5 (>5dB)
No. opening out of
3
No. opening out of
3
No. opening out of
3
✓
✓
✘
✓
3 out of 5 <5dB
2 out of 3 no open
2 out of 3 no open
2 out of 3 no open
✓
✘
✓
✘
✓
✘
✓
✘
Passive & active
opening
Tubomanometry
Tuboimpedance
No open or R>1
@30mbar
No open @30mbar
✓
✘
No open or R>1
@300daPa
No open @300daPa
✓ ✓ ✓ ✓
All Expert panel NA NA NA Obstructive ETD
diagnosis
✓ ✓
�CETDA and ETDQ-7 included in separate models: model variant ‘a’ includes CETDA score and ‘b’ includes ETDQ7 score: the similarity of the PROMs precluded
inclusion alongside one another in the models.
✓ indicates tests selected for inclusion in the regression models and latent class analyses. Regression and LCA models evolved as tests were removed during analysis due
to poor performance:
✘ indicates that the index test was removed during analysis. ME = Middle Ear, TTAG = Tubo-tympano-aerodynamic-graphy
https://doi.org/10.1371/journal.pone.0206946.t005
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audiometry. Although largely unmeasured, the assumption has been that the clinical diagnosis
reliably translates to the ability of the ET to perform its physiological functions; opening to
permit ME pressure equalisation and drainage, and protection of the middle ear. In recent
years this link has been questioned, with reports that symptoms and the results of objective
tests (tympanometry[24], tubomanometry[25, 26] and middle ear pressure equilibration tests
[27]) were not closely matched. In this study PCA and correlation matrices demonstrated that
patient symptoms measured by PROMs, and ET function measured by tests of ET opening for
OETD and PETD, appear poorly correlated and vary independently. The panel diagnosis, as a
close correlate of current clinical diagnosis, was found to be closely related to OETD symp-
toms, but not the measured underlying ET function.
Selecting an ideal reference standard for OETD
Two approaches for establishing test accuracy were explored. A consistent finding was that the
tested PROMs had limited or no value as a diagnostic tool for OETD, highlighted by the very
low Youden’s index and lack of influence on the latent class model output. While the PROMs
consistently showed good sensitivity, the 71.0% to 81.8% overall PROM positive rate in the
cohort resulted in very poor specificity. It is likely that the nature of the symptoms covered by
the PROM items meant that patients with conditions such as hearing loss, Meniere’s Disease
Table 6. The coefficients (= log odds ratio) can be used to calculate a patient’s risk of having OETD. As continuous, raw data were used, tympanogram middle ear
pressure and nine step pressure change have a negative predictive effect.
A (CETDA) B (ETDQ-7)
Clinical Model OR 95% CI Coefficient OR 95% CI Coefficient
PROM (A or B) (per point) 1.05 0.99–1.10 0.05 1.03 0.98–1.07 0.03
Tympanometry (per dPa) 0.99 0.98–1.00 -0.01 0.99 0.98–1.00 -0.01
Observed Valsalva (per x/3) 2.61 1.00–6.82 0.96 2.64 1.02–6.82 0.97
Observed Toynbee (per x/3) 1.21 0.40–3.67 0.19 1.25 0.42–3.76 0.23
Reported Toynbee (per x/3) 1.68 0.60–4.71 0.52 1.67 0.60–4.63 0.51
Constant -2.40 -1.85
A (CETDA) B (ETDQ-7)
Research Model OR 95% CI Coefficient OR 95% CI Coefficient
PROM (A or B) (per point) 1.05 1.00–1.11 0.05 1.03 0.98–1.07 0.03
Nine step (per dPa change) 0.99 0.98–1.01 -0.01 0.99 0.98–1.01 -0.01
Tympanometry (per dPa) 0.99 0.98–1.00 -0.01 0.99 0.98–1.00 -0.01
Impedance Toynbee (per x/3) 2.30 0.89–5.96 0.83 2.25 0.88–5.75 0.81
Observed Valsalva (per x/3) 2.21 0.89–5.44 0.79 2.29 0.94–5.60 0.83
Tubomanometry (Y/N) 1.76 0.71–4.37 0.57 1.72 0.70–4.23 0.54
Constant -2.77 -2.14
OR = odds ratio.
https://doi.org/10.1371/journal.pone.0206946.t006
Table 7. Discriminatory ability of diagnostic models for OETD.
Model c-statistic 95% CI Optimism corrected c-statistic Calibration slope
Clinical A 0.76 0.67–0.84 0.74 (SD 0.02) 0.83 (SD 0.18)
Clinical B 0.75 0.66–0.83 0.74 (SD 0.02) 0.79 (SD 0.19)
Research A 0.79 0.70–0.86 0.77 (SD 0.02) 0.80 (SD 0.18)
Research B 0.79 0.70–0.86 0.76 (SD 0.02) 0.79 (SD 0.19)
https://doi.org/10.1371/journal.pone.0206946.t007
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or temporomandibular joint (TMJ) dysfunction also scored highly, as has previously been
demonstrated[11].
The clearest difference between using the panel diagnosis and LCA was the percentage of
individuals diagnosed as OETD: approximately 49% according to the panel, and 32%
Table 8. All test latent class model: the panel diagnosis included as an index test alongside the tests of ET opening and PROMs.
Aspect of ET function evaluated Test All–Test Model a All test Model b
Sens 95%CI Spec 95% CI J Sens 95% CI Spec 95% CI J
Symptoms CETDA score 87.6 72.1–95.0 22.4 13.4–35.1 0.10 — — — — —
ETDQ-7 score — — — — — 75.3 58.7–86.8 20.2 11.9–32.2 -0.05
ME pressure equalisation Tympanometry 52.4 27.4–76.2 100.0 0.0–100.0 0.52� 54.6 30.7–76.6 100.0 0.0–100.0 0.55�
Nine step test 62.4 43.3–78.2 81.8 65.2–91.5 0.44 61.7 42.6–77.8 80.2 66.1–89.4 0.42
Passive opening Observed Valsalva 74.4 56.5–86.7 73.8 54.8–86.7 0.48 75.6 57.9–87.5 73.2 55.9–85.5 0.49
Active opening Sonotubometry 77.6 55.1–90.7 71.4 55.8–83.2 0.49 79.5 58.0–91.6 71.4 56.5–82.7 0.51�
Passive & active opening Tubomanometry 84.9 62.7–94.9 66.1 49.7–79.4 0.51� 86.4 65.6–95.5 65.7 50.3–78.4 0.52�
All Expert Panel 79.1 60.3–90.4 69.6 51.9–82.9 0.49 79.0 60.1–90.4 68.2 52.8–80.4 0.47
Percentage of cases in Class % 95% CI % 95% CI
each class No OETD 59.8 39.9–76.9 61.5 44.1–76.3
OETD 40.2 23.1–60.1 38.5 23.7–55.9
Aspect of ET function evaluated Test No-Panel Model a No-Panel Model b
Sens 95%CI Spec 95% CI J Sens 95% CI Spec 95% CI J
Symptoms CETDA score 86.6 66.3–95.5 20.8 12.7–32.1 0.07 — — — — —
ETDQ-7 score — — — — — 72.1 52.9–85.6 19.2 11.5–30.3 -0.09
ME pressure equalisation Tympanometry 61.2 30.4–85.1- 97.7 76.6–99.8 0.59� 60.6 33.6–82.3 97.2 81.9–99.7 0.58�
Nine step test 69.4 41.5–87.9 79.7 66.6–88.6 0.49 67.7 44.084.9- 78.7 65.9–87.7 0.46
Passive opening Observed Valsalva 76.1 54.5–89.5 68.7 53.3–80.8 0.45 76.9 55.2–90.0 68.8 54.8–80.1 0.46
Active opening Sonotubometry 87.0 58.2–97.0 69.9 53.5–82.4 0.57� 89.2 59.6–97.9 70.7 55.7–82.3 0.60�
Passive & active opening Tubomanometry 90.9 67.4–97.9 62.7 46.2–76.7 0.54� 92.0 68.7–98.4 63.0 47.9–75.9 0.55�
All Expert Panel — — — — — — — — — —
Percentage of cases in Class % 95% CI % 95% CI
each class No OETD 68.1 47.4–83.5 68.3 50.9–81.8
OETD 31.9 16.4–52.5 31.6 18.2–49.0
Aspect of ET function evaluated Test No-PROM Model Open-Test Model
Sens 95%CI Spec 95% CI J Sens 95% CI Spec 95% CI J
Symptoms CETDA score — — — — — — — — — —
ETDQ-7 score — — — — — — — — — —
ME pressure equalisation Tympanometry 54.1 29.8–76.5 100.0 0.0–100.0 0.54� 60.0 32.5–82.3 97.6 79.5–99.8 0.58�
Nine step test 62.0 42.9–78.0 80.6 66.2–89.9 0.43 68.0 43.5–85.4 79.4 66.5–88.2 0.47
Passive opening Observed Valsalva 75.2 57.5–87.2 73.3 55.6–85.7 0.49 76.2 55.0–89.3 69.1 54.4–80.7 0.45
Active opening Sonotubometry 78.9 57.3–91.3 71.3 56.3–82.8 0.50 87.7 59.5–97.2 70.7 55.2–82.5 0.58�
Passive & active opening Tubomanometry 86.2 65.1–95.4 65.9 50.2–78.8 0.52� 91.3 68.4–98.1 63.3 47.6–76.6 0.55�
All Expert Panel 79.0 60.0–90.4 68.5 52.7–80.9 0.48 — — — — —
Percentage of cases in Class % 95% CI % 95% CI
each class No OETD 61.0 43.1–76.5 67.6 49.1–81.8
OETD 39.0 23.5–56.9 32.4 18.1–50.1
‘a’ model includes the CETDA whereas ‘b’ model includes the ETDQ-7. No-panel latent class model: the All-test model without the panel diagnosis. No-PROM latent
class model: the All-test model without the PROM). Open-test latent class model: only tests that measure ET opening included. Sens = sensitivity, Spec = specificity, J =
Youden’s index (J) (� if >0.5),— = Not included, Impedance Toynbee (not shown) was excluded during analysis.
https://doi.org/10.1371/journal.pone.0206946.t008
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according to LCA models without the panel (39% incorporating the panel). This difference
had the effect of producing lower sensitivity values for the tests of ET opening when using the
expert panel as the reference standard.
There are two possible reasons for the differences between reference diagnoses:
1. OETD was over-diagnosed clinically. Clinical diagnosis relies heavily on symptoms since
examination and basic tests may both be normal. Symptoms are non-specific, as confirmed
by the PROM performance, and so there may have been a high false positive rate in the
panel diagnoses. Based on the PETD opening test results, clinical over-diagnosis of PETD
may also have occurred.
2. Test of ET opening under-diagnose OETD. ET function may vary over time, and in some
patients in whom OETD is intermittent the single testing episode may have occurred dur-
ing a period of normal ET function, leading to a false negative. An example may be those
patients who only suffer OETD during significant ambient pressure changes (baro-chal-
lenge). By re-testing individuals after an interval[10], on a separate day, or even under dif-
ferent conditions such as in a pressure chamber[28], it may be that intermittent OETD can
be detected in more ears. Alternatively, the tests of ET opening may fail to diagnose those
who only have a mild form of the disorder, perhaps because the obstructed ET still opens
under the non-physiological conditions during many of the tests, or in the case of PETD,
the ET opens and closes in a normal manner except during exercise or other provocation.
The expert panel consensus process demonstrated that even experienced clinicians could
not agree on the diagnosis for certain patients, and together with the poor correlation with
tests of ET opening, this suggests that the panel diagnosis reference standard may be imperfect.
However, completely removing the clinical acumen of an experienced clinician from the diag-
nostic process for ETD risks the loss of a highly-sophisticated diagnostic ‘test’. Although the
tests of ET opening were found to correlate with each other, and measure physiologically
important aspects of ET function such as ME pressure equalisation, there are likely to be more
aspects to normal ET function than can be objectively measured currently. The LCA No-
PROM model (given the lack of diagnostic value from PROMs) therefore appears an attractive
experimental means to combine clinical diagnosis with measured ET function.
Table 9. Time to complete each test and patient-reported difficulty/discomfort.
Reported by patient
ET Opening Test Repetitions Time to complete
Mean (SD)
Difficulty /10
Median (range)
Discomfort /10
Median (range)
Tympanometry 1 1m 4s (34s) 1 (1–2) 1 (1–3)
Nine-step test 1 6m 28s (82s) 1 (1–5) 1 (1–7)
Patient-report &
TM observation
6+1� 3m 3s (51s) 1 (1–6) 2 (1–8)
TTAG 6+1� 5m 37s (78s) 1 (1–4) 2 (1–9)
Impedance 6+1� 6m 3s (85s) 2 (1–6) 1 (1–6)
Sonotubometry 5+1� 3m 53s (50s) 1 (1–6) 1 (1–6)
Tubomanometry 3 7m 53s (138s) 3 (1–10) 3 (1–8)
Tuboimpedance 3 6m 35s (143s) 3 (1–10) 2 (1–8)
Values for patient-report and tympanic membrane (TM) observation were recorded together. TTAG = Tubo-tympano-aerodynamic-graphy.
� = additional PETD test for heavy breathing performed with OETD tests
https://doi.org/10.1371/journal.pone.0206946.t009
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Clinical and research implications: Diagnosing and measuring OETD
This study suggests that current methods of clinical diagnosis alone (review of a patient’s
history, examination, tympanometry and audiometry), even in the form of an expert pan-
el’s consensus opinion, may be inadequate to diagnose OETD. The panel diagnosis ana-
lysed as an index test appeared equivalent or inferior to some tests of ET opening. As
indicated by the components of the PCA, if the panel diagnosis and tests of ET opening
both measure ETD, they measure different aspects of the condition, and so are comple-
mentary, rather than alternative diagnostic tools. While the PROMs were aligned with the
panel diagnosis in the PCA, unlike the panel they were found not have diagnostic value
due to poor specificity, and so analysis using the existing PROMs should be omitted from
the diagnosis of ETD.
It appears therefore that there are two aspects of OETD that should be incorporated into
clinical and research practice when diagnosing ETD: the clinical assessment, representing
patient history, examination and symptoms (rationalised in a manner that the tested PROMs
cannot to ensure adequate specificity), and objective measures of ET function such as the tests
of ET opening. Current methods of diagnosis based on clinical assessment[1] may not select
the cohort of patients who would benefit most from interventions which are often designed to
aid ET opening. They also appear inadequate in situations where a higher certainty of diagno-
sis is required, such as when surgical interventions such as balloon Eustachian tuboplasty are
being considered, or when conducting clinical research.
This study builds on previous work to identify the most useful ET function tests in terms of
reliability and accuracy[9, 10]. Given the potential issues with the flawed nature of the expert
panel reference it appears that the results from the latent class models are more reliable, where
tympanometry, sonotubometry and tubomanometry had the highest Youden’s index and
therefore greatest potential diagnostic value for OETD.
On the basis of our data using two current PROMs, PROMs should not be used in the diag-
nosis of ETD, though they may have a role in quantifying and documenting symptoms, either
to aid in the selection of confirmed ETD patients where surgical intervention may be justified,
or if shown to be responsive, to monitor the course of disease over time or following treatment.
Current PROMs are designed to be self-completed by the subjects, which introduces variability
in the interpretation of the questions. Future research could be done into the development of
an instrument that would act as a framework for taking the medical history, inquiring about a
standard set of symptoms relevant to ETD. If validated, such an instrument might improve the
initial selection of patients for testing.
Clinical and research implications: Diagnosing and measuring PETD
For PETD, only one reference standard was assessed as the sample size of affected cases (based
on review of PETD tests of ET opening and the panel diagnosis) was deemed too small to
allow reliable latent class analysis. Nonetheless the available data represent an advance in our
understanding of tests for PETD, having investigated a number of tests in a single, clinically-
relevant mixed cohort at the same point in time. The panel diagnosis and PETD tests of ET
opening demonstrated significant correlation, suggesting that for PETD, the recognition of
characteristic features in the history[29] may ensure that clinical diagnosis reflects the mea-
sured ET function better than is the case for OETD. A diagnostic feature of PETD is reported
to be movement of the tympanic membrane synchronised with heavy breathing, and the con-
tinuous impedance and TTAG tests measuring this feature had the highest diagnostic accuracy
in this study. Sonotubometry performed poorly using the tested protocol, however newer tech-
niques may be superior[30].
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The role of test combinations
Previous work has suggested that combining different ET function tests may improve diagnos-
tic accuracy for ETD[2, 31, 32]. This was found to be the case in the regression models, where
combining either basic, currently-used tests (Clinical model) or combining basic and advanced
tests (Research model) improved the accuracy over the individual measures. Interestingly the
additional improvement in accuracy using the Research model over the Clinical model was
negligible, but this may be due to the potentially flawed expert panel reference standard, which
was shown to relate poorly to the tests of ET opening included in the Research model.
For the regression models to be clinically useful as a diagnostic tool, they must be inter-
preted via a score chart, nomogram or calculator[17] using the coefficients identified for
each test, and applying the patient’s test results to generate a probability of the patient
having OETD. Given the reference standard on which the model was built, it was felt that
a calculator based on our model would have limited clinical utility. However, the model-
ling provides further evidence that the results of ET function tests should be combined,
ideally mathematically.
Recommended ETD diagnostic pathway for clinical and research use
On the basis of our findings, and a foundation of previously published work, we now have a
much clearer understanding as to which tests of ET function should be employed, how these
tests should be interpreted, and therefore, how ETD should be diagnosed. To guide clinicians
and researchers, a diagnostic flow chart for ETD is proposed, incorporating the key assessment
steps required to establish a diagnosis of OETD or PETD (Fig 3). The pathway incorporates
tests selected on the basis of diagnostic performance, repeatability, feasibility and patient
acceptability.
Fig 3. Proposed diagnostic pathway for ETD. a, b While clinical assessment of a patient’s history and conventional examination may not be diagnostic of
ETD, they are nonetheless an important means to identify suitable patients for investigation. c Effort should be made during assessment of the clinical history to
identify habitual sniffing, as a negative middle ear pressure in these individuals may not indicate OETD, and further testing should be undertaken. d Described
diagnostic thresholds are based on the equipment and protocols used in our study, but may require adjustment if alternative methods are used e TTAG is
recommended if a tympanic membrane perforation is present. f A simple provocation test for use in clinic is asking the patient to exercise (jog on the spot or
climb a flight of stairs) prior to testing. g Consider repeating tests on a separate occasion to improve sensitivity in patients with variable ET function. Patients
with baro-challenge induced OETD may present in this group.
https://doi.org/10.1371/journal.pone.0206946.g003
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The pathway has been designed to enable the selection of patients for intervention, whether
this be for clinical practice or research. For this reason, it has been designed to maximise speci-
ficity when selecting individuals with OETD or PETD, as both clinicians and patients often
want a high level of certainty in the diagnosis before initiating an intervention.
Pathway stage 1: Clinical assessment. The pathway begins with clinical assessment,
allowing the selection of patients suspected of having ETD, and initially targeting testing at the
form of ETD thought to be most likely (OETD or PETD). Pre-selection of patients is standard
practice when tests are applied in every field of medicine, ensuring that the tested population
has a higher incidence of the target disorder, thereby reducing the cost and patient burden of
unnecessary testing and improving the predictive value of the applied tests.
Pathway stage 2: ET function tests. In patients suspected of having OETD with an intact
TM without effusion, tympanometry should be applied as the first test of ET function. This is
recommended because tympanometry has very high specificity, close to 100% in latent class
models, although sensitivity was poor. Therefore, if ME pressure measured by tympanometry
is lower than -50daPa patients can be diagnosed as having OETD without further testing. One
exception to this results from the predisposition to inappropriate (often habitual) sniffing of
some patients with PETD[33]. Clinicians should be aware that if patients admit to regular
sniffing, this may cause a transient negative ME pressure in those with intermittent PETD, and
locking of the ET at negative pressure may even create a temporary OETD.
If tympanometry is normal, or the patient reports a history of inappropriate sniffing, fur-
ther testing is warranted. Sonotubometry and tubomanometry demonstrated the best diagnos-
tic performance for OETD, and while the two tests have good correlation, they do not
diagnose exactly the same cohort. For these reasons, and to maximise diagnostic specificity, it
is currently recommended that both tests should be positive if OETD is to be diagnosed with
certainty.
While the use of tubomanometry and sonotubometry is encouraged, they are currently not
available in many centres. If this is the case, observed Valsalva has the best diagnostic perfor-
mance of the tests not requiring specialist equipment. This test does however have certain dis-
advantages, the main one being a high degree of variation between patients regarding the
nasopharyngeal pressure generated, even following training, that has been shown to affect the
rate of ET opening and therefore test outcome[9, 10]. Observed Valsalva also only tests passive
ET opening, therefore potentially missing individuals with OETD due to failure of active ET
opening. If the tympanic membrane is not intact, basic methods for objectively measuring ET
function are currently not available.
For patients suspected of having PETD, the detection of ME pressure changes synchronised
with nasopharyngeal pressure changes on breathing appears to be the best form of diagnostic
test: although our own diagnostic study only incorporated a small sample size, the test is widely
accepted, and the mechanism for positive test results with patency of the ET is clear. Imped-
ance and TTAG methods of measurement are recommended for use in intact and perforated
TMs respectively, as both tests were found to have comparable sensitivity, specificity and ease
of use. If specialist equipment is not available, forced breathing with observation of the tym-
panic membrane provides a diagnostic option for PETD if the tympanic membrane is intact.
If patients have negative results from tests of ET opening on the side of the diagnostic path-
way they started on (i.e. testing for obstructive or patulous forms of ETD), it is suggested that
they cross over to undergo further testing for the other form of ETD. This step is suggested
due to the possibility of initial incorrect targeting of testing, on the basis of non-specific symp-
toms or examination findings.
Pathway stage 3: Repeat testing. Patients with suspected ETD who have negative tests of
ET opening for both OETD and PETD still cannot reliably be confirmed as non-ETD affected.
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The first reason for this is the intermittent nature of obstructive and patulous ETD in some
individuals, as ET function may vary over even a relatively short period[10]. If clinical suspi-
cion is high, repeat testing on another occasion is recommended in test-negative ears, to
improve the likelihood that intermittent ETD is detected[34].
A second reason for an apparent absence of ETD during testing may be that the patient’s
ETD only occurs under certain circumstances that cannot be replicated during testing, such as
during baro-challenge. For PETD, it may be possible to replicate some circumstances that pro-
voke symptoms at the time of testing, and the pathway includes a recommendation that exer-
cise is used as a simple means of provocation[29].
Pathway stage 4: Current diagnostic uncertainty. The final stage involves an assessment
as to why tests of ET opening may be negative. A diagnosis of Possible ETD is recommended
for those patients who have symptom or findings suggestive of intermittent, or situation-spe-
cific ETD (e.g. arising on baro-challenge), that we cannot detect with existing diagnostic tools
if the patient is not affected by ETD at the time of testing. If a patient’s symptoms are continu-
ous and present at, or around, the time of testing, it appears reasonable to label these individu-
als as ETD Unlikely, particularly after testing on more than one occasion.
The Possible ETD group clearly may contain individuals with an alternate diagnosis. In the
absence of additional diagnostic methods for ETD, it may be difficult to finally exclude or
detect ETD, and the clinician should consider investigating patients in this group for alternate
conditions. Care should be taken when treating patients diagnosed as Possible ETD, and it is
not recommended that this group is recruited to early-stage interventional trials.
Active and passive ET function
It is widely acknowledged that the ET may open actively (via muscular function) or passively
(due to a pressure differential), and although a predominance of active or passive dysfunction
is assumed in certain circumstances (e.g. cleft palate and rhinosinusitis respectively) the evi-
dence of this distinction from objective testing has been limited[2, 35]. While the overall good
correlation in this study between tests measuring only passive or active function suggests that
in most cases the two vary together, a distinction between active and passive ET opening was
supported by component 3 of the PCA. In future research, it would be valuable to measure
active and passive dysfunction separately and determine if patients with a predominance of
one or other dysfunction have a similar clinical course or response to interventions.
Limitations of the study
Both methods of classifying the disease status of individuals have flaws, though this study rep-
resents an advance over previous diagnostic case-control studies that relied on a single imper-
fect diagnostic method. While expert consensus may be expected to provide a more accurate
diagnosis than a single clinician, the experts in this study were handicapped by not being able
to question or examine the patients themselves, instead relying on a detailed case summary. In
their normal practice the members of the expert panel may have had access to more test results
than those provided here (audiometry and tympanometry), and so the expert diagnoses may
not fully represent the diagnostic ability of the panel members. The case summaries presented
to the panels reflected the information collected in standard practice in most ENT units, thus
ensuring blinding to the index test results to prevent incorporation bias. Expert panel mem-
bers drew attention to the importance of inappropriate (sometimes termed habitual) sniffing
in patients with PETD[33]. The presence or absence of this symptom was not recorded in the
case histories, potentially reducing the validity of tympanometry interpretation. Although
PETD opening tests suggest this was not seen in this study, some patients may have PETD and
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intermittent negative ME pressure, and the proposed diagnostic pathway has been designed to
take account of this often-misdiagnosed group.
The primary concern regarding the latent class analysis was that although efforts were
made to select index tests for inclusion that were independent, this condition could have been
violated if tests were prone to similar errors, or incorporation bias was an issue due to panel
knowledge of patients’ symptoms and tympanometry results. The latter appears not to have
been a problem as the PROMs were found to be non-diagnostic, and tympanometry results
did not correlate with the panel diagnosis.
Not all tests reported to measure or diagnose ETD could be included in this study. For
more complex tests such as sonotubometry there are multiple methods described to per-
form and interpret the tests that were not explored in this study[30, 36, 37]. Numerous
tests have been described that require a perforated tympanic membrane, and these often
allow greater analysis of tubal opening and closing[2]. Assigning equivalence between the
results of different tests in ears with intact and perforated tympanic membranes will
require further work, possibly utilising tests such as sonotubometry which do not require
a specific tympanic membrane state. This study also did not examine the role of endo-
scopic examination of the lumen of the cartilaginous ET. Although endoscopy during
dynamic manoeuvres has not been reported to be a test of ET function, the findings may
be of value in diagnosing the presence or cause of ETD, and differentiating between
obstructive and patulous forms of the disease[38]. For those tests that were included, the
findings should still be considered in the context of a relatively small sample size. The
results of this study therefore provide direction for further research.
This study was designed to overcome the limited applicability of existing case-control stud-
ies by prospectively recruiting a clinically-relevant mixed cohort of individuals with highly var-
ied forms and severity of presentation. The accuracy estimates from this study are therefore
likely to be representative of patients at other institutions. However, to ensure viability of the
study, in particular the ability to apply a wide range of tests to a single individual, certain exclu-
sion criteria were applied, such as the need for an intact tympanic membrane and aerated ME.
These requirements meant that diagnostic ability has not been assessed in all presentations of
ETD, and ETD may be more severe or prevalent in ears with a perforated tympanic membrane
or significant ME disease. Children also provide a separate population where the validity of
extrapolating data from this study is unclear. The aetiology and natural course of ETD in chil-
dren appears to differ from that in adults[39], and additional difficulty will arise in testing due
to patient understanding and compliance. However, the recommended diagnostic process
from this study provides a basis for further work in children.
Conclusions
The findings in this study demonstrate the importance of measuring ET function in clinical
practice. ETD should be diagnosed via clinical assessment combined with testing of ET open-
ing specific to OETD and PETD, in contrast to previous recommendations that symptoms
should be central to the diagnosis and definition[1]. The use of tests of ET opening may
improve the selection of candidates for intervention, and allow the objective assessment of out-
comes. Currently it is recommended that only patients with ETD diagnosed via positive tests
of ET opening should be included in interventional trials. PROMs should not be used in the
diagnostic process, but may have a role in characterising diagnosed cases and monitoring their
response to treatment. Particular importance should now be given to reducing diagnostic
uncertainty, and eliminating the need for a Possible ETD group, by developing practical ways
to detect ears with intermittent or induced ETD.
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